Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xandra Garcia-Gonzalez"'
Autor:
Elena Ramos-Ruperez, Vicente Escudero-Vilaplana, Paula Ruiz-Briones, Roberto Collado-Borrell, Cristina Villanueva-Bueno, José Luis Revuelta-Herrero, Eva González-Haba, Xandra Garcia-Gonzalez, Sara Ibañez-Garcia, Sara Perez-Ramirez, Eduardo Zatarain-Nicolás, Ana Herranz, María Sanjurjo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThe management of cardiotoxicity concerning the use of oral antineoplastic agents (OAAs) is a challenge for healthcare professionals. Our objective was to create a comprehensive medication management guide with dose adjustment recommendation
Externí odkaz:
https://doaj.org/article/53a5cf4d22e14290a294cade5ade3733
Autor:
Alicia Rodríguez, José David González San Miguel, Venancio Conesa-Garcia, Felipe Casado, Ignacio Gómez-Centurión, Úrsula Baños, Santiago Osorio, Lucia Villalon, M. Perdomo, Ferran Vall-Llovera, Juan Luis Steegmann, Rosa Ayala, Raúl Pérez-López, Valentín García-Gutiérrez, Ana Martínez-García, Jose Angel Hernandez-Rivas, María Teresa Gómez Casares, Vicente Escudero-Vilaplana, Xandra Garcia-Gonzalez, Fermín Sánchez-Guijo
Publikováno v:
Annals of hematology. 97(11)
With tyrosine kinase inhibitors (TKI), chronic myeloid leukemia (CML) patients are achieving similar rates of survival to the general population and some treatment aspects such as adherence and drug-to-drug interactions (DDI) are becoming increasingl
Autor:
Rosa Melero, Beatriz Torroba-Sanz, Marian Goicoechea, Iago Sousa-Casasnovas, Jose María Barrio, Ana María García-Prieto, Patrocinio Rodriguez-Benitez, Xandra García-González, María Sanjurjo-Sáez
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 6, p 3329 (2024)
Cardiorenal syndrome (CRS) involves joint dysfunction of the heart and kidney. Acute forms share biochemical alterations like hyperuricaemia (HU) with tumour lysis syndrome (TLS). The mainstay treatment of acute CRS with systemic overload is diuretic
Externí odkaz:
https://doaj.org/article/99d40465ca144cf58fc7df35cf18a704
Autor:
Miguel Ángel Amor-García, Sara Ibáñez-García, Xandra García-González, Teresa Mombiela, Cristina Villanueva-Bueno, Ana Herranz-Alonso, María Sanjurjo-Sáez
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Patients with pulmonary hypertension (PH) have progressive and disabling symptoms, as well as a burden of treatments and a difficult clinical evaluation that make health-related quality of life a particularly relevant endpoint in
Externí odkaz:
https://doaj.org/article/b8bf07f7ea6d44489603f2d4079c0311
Autor:
Juan Vicente-Valor, Xandra García-González, Sara Ibáñez-García, María Esther Durán-García, Ana de Lorenzo-Pinto, Carmen Rodríguez-González, Irene Méndez-Fernández, Juan Carlos Percovich-Hualpa, Ana Herranz-Alonso, María Sanjurjo-Sáez
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 146, Iss , Pp 112519- (2022)
Introduction: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have emerged as a therapeutic option for patients with hypercholesterolemia who do not attain low-density lipoprotein cholesterol (LDL-C) goals and/or are intolerant to o
Externí odkaz:
https://doaj.org/article/6c2b7dc3df8241199afc135d4d687eab
Autor:
Alicia Galar, Maricela Valerio, Pilar Catalán, Xandra García-González, Almudena Burillo, Ana Fernández-Cruz, Eduardo Zataráin, Iago Sousa-Casasnovas, Fernando Anaya, María Luisa Rodríguez-Ferrero, Patricia Muñoz, Emilio Bouza
Publikováno v:
Antibiotics, Vol 10, Iss 1, p 77 (2021)
Valganciclovir (VGCV) and ganciclovir (GCV) doses must be adjusted according to indication, renal function and weight. No specific therapeutic exposure values have been established. We aimed to evaluate the adequacy of VGCV/GCV doses, to assess the i
Externí odkaz:
https://doaj.org/article/9a8f55dfdc634a09a553a8c36a2f8848